Gain the actionable knowledge your organization needs to ensure compliance with the Medicare Drug Price Negotiation Program Final Rule. This course covers regulatory foundations from the Inflation Reduction Act, detailed requirements for manufacturers and Part D sponsors, drug selection processes, reporting, enforcement, and compliance strategies. Learn how CMS will negotiate prescription drug prices, key deadlines, penalties for non-compliance, and the impact on market access. Ideal for regulatory, legal, and compliance professionals seeking to meet Medicare’s new standards.
In this course you will learn the following:
* Understand the statutory and regulatory requirements of the Negotiation Program.
* Identify compliance obligations for manufacturers, Part D sponsors, and other stakeholders.
* Learn actionable steps for implementation and reporting.
* Recognize consequences of non-compliance, including civil monetary penalties.
* Prepare for timelines, deadlines, and phased implementation.
* Understand the impact on drug selection, negotiation, and beneficiary access.
